UNASSIGNED:     OBJECTIVE: To explore the effect of glycated hemoglobin (HbA1c) and albumin-corrected glycated serum proteins ( @entity2313 - @entity23756 ) on the mortality of @entity6 @entity1 receiving continuous @entity298 ( @entity298 ).     METHODS: In this single-center retrospective cohort study, incident @entity6 @entity1 from January 1, 2006, to December 31, 2010, were recruited, and followed up until December 31, 2011. The effect of HbA1c and @entity2313 - @entity23756 on mortality was evaluated by Cox proportional hazards models.     RESULTS: A total of 200 @entity1 (60% male, mean age 60.3    10.6 years) with a mean follow-up of 29.0 months (range: 4.3 - 71.5 months) were recruited. Sixty-four @entity1 died during the follow-up period, of whom 21 died of @entity65 ( @entity65 ). Mean values for HbA1c, @entity23756 and @entity2313 - @entity23756 were 6.7% (range: 4.1 - 12.5%), 202  mol/L (range: 69 - 459  mol/L), and 5.78  mol/g (range: 2.16 - 14.98  mol/g), respectively. The concentrations of @entity23756 and @entity2313 - @entity23756 were closely correlated with HbA1c (r = 0.41, p < 0.001 and r = 0.45, p < 0.001, respectively). In multivariate Cox proportional hazards models, @entity1 with HbA1c >=  8% were associated with increased risk of all-cause mortality (hazard ratio [HR] = 2.29, 95% confidence interval [CI]: 1.06 - 4.96, p = 0.04), but no increased mortality in @entity1 with 6.0%  <= HbA1c  <= 7.9%. @entity1 with @entity2313 - @entity23756  <= 4.50  mol/g had increased all-cause and non-cardiovascular mortality (HR = 2.42, 95% CI: 1.13 - 5.19, p = 0.02; and HR = 2.98, 95% CI: 1.05 - 8.48, p = 0.04 respectively).     CONCLUSIONS: Increased @entity4051 c and decreased @entity2313 - @entity23756 may be associated with poorer survival in @entity6 @entity1 , with a non-significant trend observed for poorer survival with the highest level of @entity2313 - @entity23756 .

The Effect of Glycated Hemoglobin and Albumin-Corrected Glycated Serum Protein on Mortality in @entity6 XXXX Receiving Continuous Peritoneal Dialysis.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity2313 :: ('213', 'Gene') :: ['Alb'] @entity4051 :: ('3039', 'Gene') :: ['HbA1'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetic', 'diabetic PD'] @entity23756 :: ('2933', 'Gene') :: ['GSP'] @entity65 :: ('MESH:D002318', 'Disease') :: ['CVD', 'cardiovascular disease'] @entity298 :: ('MESH:D010538', 'Disease') :: ['peritoneal dialysis', 'PD']
@entity1 :: (9606,Species) :: ['Patients']
